Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid Leukemia: A Pilot Study.
Kelly A HylandAshley M NelsonSarah L EiselAasha I HooglandJavier Ibarz-PinillaKendra SweetPaul B JacobsenHans KnoopHeather S L JimPublished in: Annals of behavioral medicine : a publication of the Society of Behavioral Medicine (2021)
CBT-TTF appears to improve TKI-related fatigue in CML patients through changes in behavior (sleep, activity patterns) and cognitions about fatigue and cancer. A larger randomized controlled trial is warranted to confirm these findings.
Keyphrases
- chronic myeloid leukemia
- sleep quality
- randomized controlled trial
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- study protocol
- peritoneal dialysis
- physical activity
- depressive symptoms
- prognostic factors
- clinical trial
- tyrosine kinase
- patient reported outcomes
- squamous cell
- young adults
- drug induced
- patient reported
- epidermal growth factor receptor